Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 8 | 2022 | 297 | 0.890 |
Why?
|
| Fractional Flow Reserve, Myocardial | 5 | 2022 | 126 | 0.840 |
Why?
|
| Aneurysm, False | 2 | 2020 | 44 | 0.830 |
Why?
|
| Coronary Vessels | 3 | 2021 | 152 | 0.800 |
Why?
|
| Aortic Valve Stenosis | 2 | 2022 | 60 | 0.740 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 389 | 0.730 |
Why?
|
| Coronary Artery Disease | 5 | 2022 | 274 | 0.730 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 75 | 0.730 |
Why?
|
| Heart Aneurysm | 1 | 2019 | 13 | 0.680 |
Why?
|
| Systole | 1 | 2019 | 68 | 0.670 |
Why?
|
| Heart Ventricles | 2 | 2019 | 249 | 0.650 |
Why?
|
| Coronary Stenosis | 4 | 2021 | 99 | 0.640 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 78 | 0.580 |
Why?
|
| Ventricular Remodeling | 1 | 2017 | 54 | 0.570 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 477 | 0.370 |
Why?
|
| Coronary Angiography | 9 | 2022 | 334 | 0.330 |
Why?
|
| Neoplasms | 1 | 2018 | 1235 | 0.310 |
Why?
|
| Stents | 5 | 2022 | 338 | 0.310 |
Why?
|
| Heart Failure | 2 | 2022 | 458 | 0.260 |
Why?
|
| Treatment Outcome | 10 | 2022 | 5141 | 0.220 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2020 | 5 | 0.190 |
Why?
|
| Glycosides | 1 | 2020 | 17 | 0.190 |
Why?
|
| Cardiovascular System | 1 | 2020 | 49 | 0.180 |
Why?
|
| Humans | 17 | 2022 | 49974 | 0.180 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 903 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2016 | 984 | 0.160 |
Why?
|
| Prognosis | 3 | 2018 | 1942 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2020 | 201 | 0.150 |
Why?
|
| Incidence | 2 | 2018 | 1003 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 169 | 0.150 |
Why?
|
| Femoral Artery | 2 | 2014 | 100 | 0.140 |
Why?
|
| Kidney | 1 | 2020 | 665 | 0.140 |
Why?
|
| Absorbable Implants | 1 | 2015 | 16 | 0.130 |
Why?
|
| Coronary Thrombosis | 1 | 2015 | 23 | 0.130 |
Why?
|
| Coronary Restenosis | 1 | 2015 | 31 | 0.130 |
Why?
|
| Aged | 5 | 2022 | 9310 | 0.130 |
Why?
|
| Time Factors | 5 | 2022 | 2903 | 0.120 |
Why?
|
| Popliteal Artery | 1 | 2014 | 26 | 0.120 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 22 | 0.120 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 33 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 549 | 0.120 |
Why?
|
| Vascular Patency | 1 | 2014 | 82 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 46 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2014 | 66 | 0.110 |
Why?
|
| Hospitalization | 3 | 2022 | 652 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 173 | 0.100 |
Why?
|
| Male | 6 | 2022 | 25241 | 0.090 |
Why?
|
| Risk Factors | 3 | 2022 | 3613 | 0.080 |
Why?
|
| Registries | 2 | 2021 | 522 | 0.070 |
Why?
|
| Cause of Death | 2 | 2020 | 143 | 0.070 |
Why?
|
| Quebec | 2 | 2016 | 13 | 0.060 |
Why?
|
| Drug-Eluting Stents | 2 | 2015 | 93 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2015 | 237 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 2364 | 0.050 |
Why?
|
| Glucosides | 1 | 2020 | 16 | 0.050 |
Why?
|
| Vasodilation | 1 | 2021 | 96 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 366 | 0.050 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2020 | 18 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2022 | 113 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 111 | 0.050 |
Why?
|
| Pericardium | 1 | 2020 | 29 | 0.050 |
Why?
|
| Ischemia | 1 | 2021 | 153 | 0.040 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 67 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2182 | 0.040 |
Why?
|
| Sex Factors | 1 | 2022 | 691 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 402 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2020 | 214 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 375 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 1422 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 12069 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2022 | 1259 | 0.040 |
Why?
|
| Female | 4 | 2022 | 26472 | 0.030 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2015 | 7 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 492 | 0.030 |
Why?
|
| Metals | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 440 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2015 | 48 | 0.030 |
Why?
|
| Ticlopidine | 1 | 2015 | 55 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 100 | 0.030 |
Why?
|
| Radial Artery | 1 | 2014 | 29 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 94 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 54 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 224 | 0.030 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 65 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2016 | 409 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 172 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 652 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 945 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 894 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 3129 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6108 | 0.010 |
Why?
|